EFFEXOR

LOE Approaching

venlafaxine hydrochloride

NDAORALTABLET
Approved
Dec 1993
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
12

Mechanism of Action

MDD, GAD, SAD, and PD is unclear, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of their reuptake.

Indications (1)

Clinical Trials (5)

NCT02958527N/ACompleted

Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)

Started Oct 2016
1,408 enrolled
Depression/Depressed State
NCT02637193Phase 1Completed

A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects

Started Dec 2015
54 enrolled
Healthy Subjects
NCT01235338Phase 1Completed

Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers

Started Oct 2010
80 enrolled
Healthy
NCT00878748Phase 4Withdrawn

Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder

Started Apr 2009
0
Major Depressive Disorder
NCT00362271Phase 1Completed

Aripiprazole and Effexor XR Drug Interaction Study

Started Aug 2006
38 enrolled
Healthy